newsfilter
← Latest News
Business Wire·

Sierra Oncology Announces Momelotinib Poster Accepted for Presentation at ASH

Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer, today announced new retrospective analyses of the momelotinib Phase 3 SIMPLIFY studies will be presen